Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo
Daniel G. Bausch*1 , Matthias Borchert†2, Thomas Grein‡, Cathy Roth‡, Robert Swanepoel§, Modeste L. Libande¶, Antoine Talarmin#3, Eric Bertherat**4, Jean-Jacques Muyembe-Tamfum¶, Ben Tugume††, Robert Colebunders†, Kader M. Kondé‡‡5, Patricia Pirard§§, Loku L. Olinda¶, Guénaël R. Rodier‡, Patricia Campbell¶¶, Oyewale Tomori‡‡, Thomas G. Ksiazek*, and Pierre E. Rollin*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta Georgia, USA; †Institute of Tropical Medicine, Antwerp, Belgium; ‡World Health Organization, Geneva, Switzerland; §National Institute for Communicable Diseases, Johannesburg, South Africa; ¶Ministry of Health, Kinshasa, Democratic Republic of the Congo; #Institut Pasteur, Cayenne, French Guiana; **Le Pharo, Marseille, France; ††Uganda Virus Research Institute, Entebbe, Uganda; ‡‡World Health Organization, AFRO, Harare, Zimbabwe; §§Doctors without Borders, Brussels, Belgium; ¶¶Doctors without Borders, Amsterdam, the Netherlands; 1Present address: Tulane School of Public Health and Tropical Medicine, New Orleans, LA, USA.; 2Present address: London School of Hygiene and Tropical Medicine, London, England.; 3Present address: Institut Pasteur, Bangui, Central African Republic.; 4Present address: World Health Organization, Geneva, Switzerland.; 5Present address: World Health Organization, AFRO, Ouagadougou, Burkina Faso.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.